HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group.

AbstractOBJECTIVE:
To develop the Lens Opacities Classification System III (LOCS III) to overcome the limitations inherent in lens classification using LOCS II. These limitations include unequal intervals between standards, only one standard for color grading, use of integer grading, and wide 95% tolerance limits.
DESIGN AND RESULTS:
The LOCS III contains an expanded set of standards that were selected from the Longitudinal Study of Cataract slide library at the Center for Clinical Cataract Research, Boston, Mass. It consists of six slit-lamp images for grading nuclear color (NC) and nuclear opalescence (NO), five retroillumination images for grading cortical cataract (C), and five retroillumination images for grading posterior subcapsular (P) cataract. Cataract severity is graded on a decimal scale, and the standards have regularly spaced intervals on a decimal scale. The 95% tolerance limits are reduced from 2.0 for each class with LOCS II to 0.7 for nuclear opalescence, 0.7 for nuclear color, 0.5 for cortical cataract, and 1.0 for posterior subcapsular cataract with the LOCS III, with excellent interobserver agreement.
CONCLUSION:
The LOCS III is an improved LOCS system for grading slit-lamp and retroillumination images of age-related cataract.
AuthorsL T Chylack Jr, J K Wolfe, D M Singer, M C Leske, M A Bullimore, I L Bailey, J Friend, D McCarthy, S Y Wu
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 111 Issue 6 Pg. 831-6 (Jun 1993) ISSN: 0003-9950 [Print] United States
PMID8512486 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Aging (physiology)
  • Case-Control Studies
  • Cataract (classification)
  • Evaluation Studies as Topic
  • Humans
  • Lens Cortex, Crystalline (pathology)
  • Lens Nucleus, Crystalline (pathology)
  • Observer Variation
  • Photography
  • Reference Standards

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: